Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

If you know how viruses get into cells, you know how to better design drugs to keep them out

When it comes to gaining entry into cells, size matters. A team from Brown University and the Max Planck Institute for Metals Research has created a model that explains how viruses and other bioparticles slip inside cells without a special protein coating called clathrin.

27 Jun 2005

Light used to regulate protein synthesis

Proteins are the puzzle-pieces of life, involved in how organisms grow and flourish, but studying their complex biological processes in living systems has been extremely difficult.

27 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Calcitonin, a hormone that lowers calcium levels in the blood and prevents bone loss, has only been available in an injectable and nasally-administered format to date.

1 Jun 2005

Ranbaxy makes further three filings of its Anti-Retroviral (ARVs) formulations

Ranbaxy Laboratories Limited has announced that the Company has made further three filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organization (WHO) for its approval under the latter's pre-qualification project for HIV/AIDS drugs.

30 May 2005

Discovery of a fundamental new route into cells may lead to new methods of drug delivery

Researchers from The University of Queensland’s Institute for Molecular Bioscience (IMB), and the Centre for Microscopy and Microanalysis used electron microscopy to uncover new structures, 100,000th of a mm in size, which are involved in the very first step of particle and nutrient uptake into cells.

10 May 2005

Major Chinese breakthrough for pSivida - patent granted

This first patent grant in China is important as China has the highest incidence of primary liver cancer in the world with 345,844 cases in 2002 and is a logical target market for BrachySil. The potential lower cost of the Chinese registration pathway and the vast need of BrachySil like products make China an important commercial target.

9 May 2005

Chemical library aids in developing drug system for nerve damage

A researcher studying drug design for nerve damage therapies has gotten her answer to questions by following some old advice: she used the library.

12 Apr 2005

Significant progress in pSivida BioSilicon drug delivery evaluation

Global nanotechnology company pSivida Limited has announced that its evaluation of selected compounds from an undisclosed top five global pharmaceutical company has progressed successfully.

11 Apr 2005

Ranbaxy files additional Anti-Retroviral (ARV) agents with the World Health Organization

Ranbaxy Laboratories Limited (RLL) announced today that the Company has made two additional filings of its Anti-Retroviral (ARV) agents with the World Health Organization (WHO) for its approval, taking the total number of Ranbaxy ARV filings submitted with the WHO to five.

23 Mar 2005

Smart nanocarrier technology will cancer treatment

A ‘smart’ nanocarrier technology developed by a team of researchers at the Institute of Bioengineering and Nanotechnology (IBN) is set to vastly improve the way cancer patients are treated.

22 Mar 2005

pSivida intensifies research activities

Following extremely encouraging Phase IIa clinical trial results showing successful tumor regression and safety in man, nanotechnology pioneer pSivida Limited is intensifying development of its fully patented invention of nanostructured bioactive, biodegradable and biocompatible silicon (BioSilicon™) for multiple potential healthcare applications.

21 Mar 2005

MicroJet injector for painless injections

Parents know all too well the pain experienced by their children - and themselves - when the time comes for immunizations at the doctor's office.

21 Mar 2005

African malaria comes to town

First, the bad news: urban malaria in Africa is becoming a major health problem and looks set to get worse.

17 Mar 2005

Fundamental mechanisms that may facilitate the design of safer and more efficacious topical drug delivery systems

In a paper published in the Proceedings of the National Academy of Sciences, a group of researchers led by Samir Mitragotri, a professor of chemical engineering at the University of California, Santa Barbara, reports the identification of fundamental mechanisms that may facilitate the design of safer and more efficacious topical drug delivery systems.

16 Mar 2005

Nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009

According to a new report by NanoMarkets, an industry consultancy based here, nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009 and grow to $2.5 billion in 2012.

8 Mar 2005

Future out-licensing of BioSilicon in tissue engineering and orthopedics

Global nanotechnology company pSivida Limited has announced that it has signed an agreement with US based PureTech Development LLC to investigate and evaluate out-licensing opportunities for BioSilicon with an emphasis on tissue engineering, wound management and orthopedics.

28 Feb 2005

Medical House signs 10 year license and supply agreement with BioPartners GmbH

The Medical House, orthopaedic devices and drug delivery company and BioPartners GmbH the global biopharmaceuticals company are pleased to announce a 10 year agreement for license and supply of The Medical House's GH1 reusable, spring-powered, needle-free delivery system for the delivery of BioPartners’ human growth hormone product, Valtropin.

22 Feb 2005

Testosterone spray improves younger women's sexual enjoyment and satisfaction

Improved sexual satisfaction for women could be just a spray on the skin away, according to the results of clinical trials led by a Monash University research team.

10 Feb 2005

Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications.

8 Feb 2005

Drug Delivery News and Research

Further Reading

If you know how viruses get into cells, you know how to better design drugs to keep them out

Light used to regulate protein synthesis

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Ranbaxy makes further three filings of its Anti-Retroviral (ARVs) formulations

Discovery of a fundamental new route into cells may lead to new methods of drug delivery

Major Chinese breakthrough for pSivida - patent granted

Chemical library aids in developing drug system for nerve damage

Significant progress in pSivida BioSilicon drug delivery evaluation

Ranbaxy files additional Anti-Retroviral (ARV) agents with the World Health Organization

Smart nanocarrier technology will cancer treatment

pSivida intensifies research activities

MicroJet injector for painless injections

African malaria comes to town

Fundamental mechanisms that may facilitate the design of safer and more efficacious topical drug delivery systems

Nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009

Future out-licensing of BioSilicon in tissue engineering and orthopedics

Medical House signs 10 year license and supply agreement with BioPartners GmbH

Testosterone spray improves younger women's sexual enjoyment and satisfaction

Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

Event guide: World ADC Asia eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery